Safeguard Scientifics files Form 25 to voluntarily delist from Nasdaq

Safeguard Scientifics filed Form 25 with the Securities and Exchange Commission to voluntarily delist its shares of common stock from trading on The Nasdaq Stock Market in connection with its previously announced plan to deregister its common stock under the Securities Exchange Act of 1934, as amended, and to delist the Company’s common stock from trading on Nasdaq. The Company expects that the delisting will occur ten days after the filing of Form 25 so that trading will be suspended on February 12, 2024 prior to the market opening, at which point, the Company intends to file a Form 15 with the SEC certifying that it has less than 300 shareholders of record, which will terminate the registration of the Company’s common stock under Section 12(g) of the Exchange Act. Following the delisting of the Company’s common stock from trading on Nasdaq, any trading in the Company’s common stock would only occur in privately negotiated sales and potentially on an over-the-counter market. The Company expects to have its common stock quoted on a market operated by OTC Markets Group so that a trading market may continue to exist for its common stock. There is no guarantee, however, that a broker will continue to make a market in the common stock and that trading of the common stock will continue on an OTC market or otherwise.